This firm's average rating is Buy from 3 analysts. We provide trade advice to complement the prevailing
expert consensus on Auris Medical Holding. Our dynamic recommendation engine uses a multidimensional algorithm to analyze the company's potential to grow using all technical and fundamental data available at the time.
Use Technical Analysis to project Auris expected Price
Auris Medical technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, delisted stock market cycles, or different charting patterns.
A focus of Auris Medical technical analysis is to determine if market prices reflect all relevant information impacting that market. A technical analyst looks at the history of Auris Medical trading pattern rather than external drivers such as economic, fundamental, or social events. It is believed that price action tends to repeat itself due to investors' collective, patterned behavior. Hence technical analysis focuses on identifiable price trends and conditions.
More Info...A Deeper Perspective
The latest fall in stock price could raise concerns from retail investors as the firm it trading at a share price of
0.81 on very low momentum in volume. The company executives have failed to build on market volatilities in
October. However, diversifying your overall positions with Auris Medical Holding may protect your principal portfolio during upcoming market swings. The stock standard deviation of daily returns for 30 days investing horizon is currently 5.33. The very high volatility is mostly attributed to the latest market swings and not very good earnings reports from some of the Auris Medical partners.
| 2017 | 2018 | 2019 | 2020 (projected) |
Current Assets | 15.87 M | 6.06 M | 2.37 M | 2.44 M | Total Assets | 17.83 M | 9.88 M | 9.23 M | 9.47 M |
Tax Assets Breakdown
Auris Medical Tax Assets yearly trend continues to be relatively stable with very little volatility. Tax Assets are likely to drop to about 29.3
K. Tax Assets usually refers to a component of Total Assets representing tax assets and receivables. Auris Medical Tax Assets are relatively stable at the moment as compared to the past year. Auris Medical reported last year Tax Assets of 29,484.9
| 2010 | 32,761 |
| 2019 | 29,484.9 |
| 2020 | 29,312.47 |
How will Auris retail investors react to the next fall?
Latest mean deviation is at 3.3. Auris Medical Holding exhibits very low volatility with skewness of 1.77 and kurtosis of 8.01. However, we advise investors to further study Auris Medical Holding technical indicators to make sure all market info is available and is reliable. Auris Medical Holding is a potential penny stock. Although Auris Medical may be in fact a good instrument to invest, many penny stocks are speculative in nature and are subject to artificial price hype. Please make sure you totally understand the upside potential and downside risk of investing in Auris Medical Holding. We encourage investors to look for the signals such us email spams, message board hypes, claims of breakthroughs, volume upswings, sudden news releases, promotions that are not reported, or demotions released before SEC filings. Please also check biographies and work history of current and past company officers before investing in high volatility instruments, penny stocks, or equities with microcap classification. You can indeed make money on this equity instrument if you perfectly time your entry and exit. However, remember that penny stocks that have been the subject of an artificial hype usually unable to maintain its increased share price for more than just a few days. The price of a promoted high volatility instrument will almost always revert back. The only way to increase shareholder value is through legitimate performance backed up by solid fundamentals.
The Current Takeaway on Auris Medical Investment
While some other companies in the biotechnology industry are either recovering or due for a correction, Auris Medical may not be performing as strong as the other in terms of long-term growth potentials. The inconsistency in the assessment between current Auris valuation and our trade advice on Auris Medical is due to the recent market swings and your selection of investing horizon. Please use our equity advice module to run different scenarios to ensure your current risk level and investment horizon are fully reflective of your current investing preferences in regards to Auris Medical.
Building efficient market-beating portfolios requires time, education, and a lot of computing power!
The Portfolio Architect is an AI-driven system that provides multiple benefits to our users by leveraging cutting-edge machine learning algorithms, statistical analysis, and predictive modeling to automate the process of asset selection and portfolio construction, saving time and reducing human error for individual and institutional investors.
Try AI Portfolio ArchitectEditorial Staff
Raphi Shpitalnik is a Junior Member of Macroaxis Editorial Board. Raphael is a young entrepreneur who joined Macroaxis on a part-time basis at the beginning of the pandemic and eventually acquired a real taste for investing and fintech. He likes to analyze different equity instruments across a wide range of industries, focusing primarily on consumer products, sports, fintech, cannabis, and AI.
View Profile This story should be regarded as informational only and should not be considered a solicitation to sell or buy any financial products. Macroaxis does not express any opinion as to the present or future value of any investments referred to in this post. This post may not be reproduced without the consent of Macroaxis LLC. Macroaxis LLC and Raphi Shpitalnik do not own shares of Auris Medical Holding. Please refer to our
Terms of Use for any information regarding our disclosure principles.
Would you like to provide feedback on the content of this article?
You can get in touch with us directly or send us a quick note via email to
editors@macroaxis.com
